Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that acts by inhibiting cyclooxygenase (COX) enzymes, thereby reducing prostaglandin synthesis and mitigating inflammatory pain responses. When used for cluster headache, it provides rapid analgesic effects by blocking peripheral pain mediators and potentially interrupting the inflammatory cascade associated with the headache pathophysiology.